Boston Scientific (NYSE: BSX) last traded at $43.08, up 0.81% on the session. The quote above updates while this page is open; the figures below are drawn from Boston Scientific’s own filings and are restated only when a new one is published.
Boston Scientific trades on NYSE under the ticker BSX. It is classified in the Healthcare sector, Medical Devices industry. Its market capitalisation is $62.43 billion.
Healthcare sectorMedical DevicesListed on NYSE
Valuation measures for Boston Scientific, derived from the latest quote and its most recent SEC filing.
| Market cap | $62.43B |
|---|---|
| Enterprise value | $81.93B |
| P/E ratio | 17.44 |
| Price / sales | 2.97 |
| Price / book |
|---|
| 2.50 |
| Beta | 0.17 |
|---|
Trailing-twelve-month figures tagged in Boston Scientific's XBRL filings with the SEC.
| Revenue (TTM) | $21.00B |
|---|---|
| Net income (TTM) | $3.67B |
| EPS (TTM) | $2.47 |
| Gross margin | 69.93% |
| Operating margin | 19.78% |
| Return on equity | 14.72% |
| Cash | $539.00M |
Range and volume for BSX over the past 52 weeks.
| 52-week high | $105.65 |
|---|---|
| 52-week low | $41.39 |
| Volume | 2.04M |
| Average volume | 19.61M |
| Previous close | $42.73 |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Boston Scientific with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BSX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.